| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | CEO Of Specialty Renal Product | President And CEO
2 companies
Evans Daron is a CFO at RZLT with holdings across 2 companies. Recent SEC Form 4 filings include 19 buys and 0 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2017 | NEPH Nephros Inc | President And CEO | Buy | 70,000 | $0.26 | $18,200.00 | +11.4% | |
| Jun 12, 2017 | NEPH Nephros Inc | President And CEO | Buy | 21,461 | $0.26 | $5,579.86 | +3.1% | |
| May 19, 2017 | NEPH Nephros Inc | President And CEO | Buy | 30,000 | $0.26 | $7,650.00 | +2.5% | |
| Mar 17, 2017 | NEPH Nephros Inc | President And CEO | Buy | 83,332 | $0.00 | - | New | |
| Dec 7, 2016 | NEPH Nephros Inc | President And CEO | Buy | 4,069 | $0.32 | $1,302.08 | +1.2% | |
| Dec 5, 2016 | NEPH Nephros Inc | President And CEO | Buy | 10,620 | $0.34 | $3,610.34 | +1.6% | |
| Dec 1, 2016 | NEPH Nephros Inc | President And CEO | Buy | 41,530 | $0.32 | $13,286.03 | +7.3% | |
| Aug 31, 2015 | NEPH Nephros Inc | President And CEO | Buy | 44,175 | $0.57 | $25,338.00 | +7.6% | |
| Aug 20, 2015 | NEPH Nephros Inc | President And CEO | Buy | 51,500 | $0.53 | $27,370.00 | +29.8% |